发明公开
- 专利标题: METHODS FOR THERAPEUTIC VACCINATION
- 专利标题(中): 方法的治疗性疫苗接种
-
申请号: EP99945967.0申请日: 1999-10-05
-
公开(公告)号: EP1117421A2公开(公告)日: 2001-07-25
- 发明人: STEINAA, Lucilla , MOURITSEN, Soren , NIELSEN, Klaus, Gregorius , HAANING, Jesper , LEACH, Dana , DALUM, Iben , GAUTAM, Anand , RASMUSSEN BIRK, Peter , KARLSSON, Gunilla
- 申请人: M & E Biotech A/S
- 申请人地址: Kogle Allé 6 2970 Horsholm DK
- 专利权人: M & E Biotech A/S
- 当前专利权人: M & E Biotech A/S
- 当前专利权人地址: Kogle Allé 6 2970 Horsholm DK
- 代理机构: Koefoed, Peter
- 优先权: DK98012 19981005; US105011P 19981020
- 国际公布: WO0020027 20000413
- 主分类号: A61K38/17
- IPC分类号: A61K38/17 ; A61K38/18 ; C07K14/50 ; C07K14/705 ; C07K14/71 ; C12N15/63 ; C12N5/16 ; C12N15/12
摘要:
A method is disclosed for inducing cell-mediated immunity against cellular antigens. More specifically, the invention provides for a method for inducing cytotoxic T-lymphocyte immunity against weak antigens, notably self-proteins. The method entails that antigen presenting cells are induced to present at least one CTL epitope of the weak antigen and at the same time presenting at least one foreign T-helper lymphocyte epitope. In a preferred embodiment, the antigen is a cancer specific antigen, e.g. PSM, Her2, or FGF8b. The method can be exercised by using traditional polypeptide vaccination, but also by using live attenuated vaccines or nucleic acid vaccination. The invention furthermore provides immunogenic analogues of PSM, Her2 and FGF8b, as well as nucleic acid molecules encoding these analogues. Also vectors and transformed cells are disclosed. The invention also provides for a method for identification of immunogenic analogues of weak or non-immunogenic antigens.
公开/授权文献
- EP1117421B2 METHODS FOR THERAPEUTIC VACCINATION 公开/授权日:2014-03-19
信息查询
IPC分类: